Market Overview The Italy Alzheimers Disease Diagnostics Market is integrating neuroimaging and biomarker technologies to achieve biological confirmation of Alzheimer's pathology alongside clinical cognitive assessment. The Italy Alzheimers Disease Diagnostics Market is projected to grow through 2030, driven by 3T MRI availability expansion, amyloid PET center development, CSF biomarker...